🔴 Park Ha Biological Technology is trading 5.53% down today after shareholder approval of major capital structure changes

Park Ha Biological Technology is trading at $0.44 (-5.53%) after shareholders approved major capital structure changes during a July 13 meeting.

• The approval of a significantly larger authorized share base and potential share consolidations has triggered investor concerns regarding future equity dilution.
• New governance measures, including higher Class B voting rights, have pressured sentiment due to potential shifts in corporate control.
• While broader markets showed post-close weakness, the company-specific vote on capital structure is the primary driver for the price decline.